NEW YORK, Aug 05, 2004 (United Press International via COMTEX) -- U.S. clinical trial data show evidence of a link between anti-depressant drugs and youthful suicidal tendencies, it was reported Thursday.
The new Food and Drug Administration analysis focused on 25 studies of nine drugs. It found children and teenagers who took the medicines were more likely to have behavior or thoughts that appeared suicidal than those who got placebo pills, the Wall Street Journal said.
It is a highly controversial subject. Congressional investigators have been examining the agency's decision last February to block a staffer from revealing his finding of a tie between anti-depressants and suicidal tendencies in young people, which drew on many of the same trials.
FDA officials said his conclusion was premature, and based on ambiguous data. The new FDA analysis relies on an in-depth review of the data by outside researchers.
The new findings are likely to intensify pressure on the agency to consider stronger action to limit use of the drugs by young people.
Copyright 2004 by United Press International.